Many of the treatments we take for granted today started with research that we funded including use of ultrasound scanning in pregnancy, the importance of taking folic acid in pregnancy and early research that linked HPV to cervical cancer – resulting in the first preventative school-wide vaccination programme.
Figures adjusted for inflation.
We aim to achieve this by investing in high-quality, innovative research addressing areas of unmet need, as well as developing promising researchers to become academic leaders in women's health.
Our research is selected, monitored and evaluated by our eminent Research Advisory Committee (RAC), a team of established and expert clinicians and researchers.
Our rigorous selection procedure and independent peer review process guarantees that we fund only the highest quality research. This ensures that our funds are invested strategically to achieve the greatest impact on improving healthcare for women, girls and babies.
We are accredited by the Association of Medical Research Charities (AMRC) and we work collaboratively with key partners including the government and the royal colleges such as the Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM).Download our research strategy
Wellbeing of Women has invested £134,193 into Dr Sarah McClelland’s research into preventing chemotherapy resistance in ovarian cancerRead more
Wellbeing of Women has invested £197,931 in Dr Ashley Boyle’s research into how bacteria can cause brain damage in premature babiesRead more
Wellbeing of Women has invested £6,211 in Professor Marian Knight’s research into what treatment is best for pregnant women who go to hospital with severe COVID-19Read more
Consultant Gynaecological Oncologist, Lancashire Teaching Hospitals NHS Trust
Clinical Senior Lecturer in Women’s Health and Reproductive Medicine, Queen Mary University of London